FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Goldberg

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Katherine Van Loon; Alan P Venook; Devin Wigler; Donna Niedzwiecki; Leonard Saltz; Charles Blanke; Charles Fuchs; Richard M Goldberg; Jeffrey A Meyerhardt
Comparison of Dietary and Lifestyle Habits Among Stage III and Metastatic Colorectal Cancer Patients: Findings from CALGB 89803 and CALGB 80405.
Laura Raftery; Joel E Tepper; Mebea Aklilu; Stephen A Bernard; A. William Blackstock; Janine M Davies; Richard M Goldberg; Anastasia Ivanova; Bert H O'Neil
A Two-cohort Phase I Study of Weekly Oxaliplatin and Gemcitabine, Then Oxaliplatin, Gemcitabine, and Erlotinib During Radiotherapy for Unresectable Pancreatic Carcinoma.
Alan P Venook; Robert S Warren; Xing Ye; Kim Clark-Langone; Wendy Frankel; Paula N Friedman; Richard M Goldberg; Mark Lee; Margarita Lopatin; Najjia N Mahmoud; Carl Millward; Donna Niedzwiecki; Richard L Schilsky; Steven Shak; Monica M Bertagnolli
Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Goldberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Katherine Van Loon; Alan P Venook; Devin Wigler; Donna Niedzwiecki; Leonard Saltz; Charles Blanke; Charles Fuchs; Richard M Goldberg; Jeffrey A Meyerhardt
Comparison of Dietary and Lifestyle Habits Among Stage III and Metastatic Colorectal Cancer Patients: Findings from CALGB 89803 and CALGB 80405.
Clinical colorectal cancer 2013;12(2):95-102.
2013: Laura Raftery; Joel E Tepper; Mebea Aklilu; Stephen A Bernard; A. William Blackstock; Janine M Davies; Richard M Goldberg; Anastasia Ivanova; Bert H O'Neil
A Two-cohort Phase I Study of Weekly Oxaliplatin and Gemcitabine, Then Oxaliplatin, Gemcitabine, and Erlotinib During Radiotherapy for Unresectable Pancreatic Carcinoma.
American journal of clinical oncology 2013;36(3):250-3.
2013: Alan P Venook; Robert S Warren; Xing Ye; Kim Clark-Langone; Wendy Frankel; Paula N Friedman; Richard M Goldberg; Mark Lee; Margarita Lopatin; Najjia N Mahmoud; Carl Millward; Donna Niedzwiecki; Richard L Schilsky; Steven Shak; Monica M Bertagnolli
Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(14):1775-81.
2013: Frank A Sinicrope; Greg Yothers; Al Benson; Aimery Degramont; Nathan R Foster; Richard M Goldberg; Roberto Labianca; Michael J O'Connell; Daniel J Sargent; Jean Francois Seitz
Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy.
Cancer 2013;119(8):1528-36.
2013: Axel Grothey; Yves Humblet; Dirk Laurent; Heinz-Josef Lenz; Laurent Mineur; Daniel J Sargent; Salvatore Siena; Alberto Sobrero; Josep Tabernero; Eric Van Cutsem; Andrea Wagner; Marc Ychou; Takayuki Yoshino; Antoine Adenis; Carlo Barone; Olivier Bouché; Frank Cihon; Lisa Cupit; Alfredo Falcone; Richard M Goldberg
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Lancet 2013;381(9863):303-12.
2012: Hanna Sanoff; Maria J Schymura; Leah L Zullig; William R Carpenter; Kun Chen; Janet Freburger; Richard M Goldberg; Ling Li; Deborah Schrag
Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.
Cancer 2012;118(17):4309-20.
2012: William R Carpenter; Richard M Goldberg; Anne-Marie Meyer; Bahjat Qaqish; Hanna Sanoff; Yang Wu; Bryan Weiner
Translating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation.
Medical care 2012;50(8):737-48.
2012: Hanna Sanoff; Maria J Schymura; Til Stürmer; William R Carpenter; Jason P Fine; Richard M Goldberg; Katherine L Kahn; Christopher F Martin; Nadine Jackson McCleary; Jeffrey A Meyerhardt; Joyce C Niland; Deborah Schrag
Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(21):2624-34.
2012: Steven R Alberts; Emily Chan; Gist H Farr; Sharlene Gill; Axel Grothey; Morton S Kahlenberg; Michelle R Mahoney; Margaret Mooney; Suresh Nair; Barbara A Pockaj; James T Quesenberry; Daniel J Sargent; Anthony F Shields; Frank A Sinicrope; Thomas C Smyrk; Stephen N Thibodeau; Thomas A Webb; Richard M Goldberg
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.
JAMA : the journal of the American Medical Association 2012;307(13):1383-93.
2012: Shuji Ogino; Leonard B Saltz; Paul Schaefer; Kaori Shima; Donna Spiegelman; Renaud Whittom; Richard M Goldberg; Alexander Hantel; Donna Hollis; Robert J Mayer; Nadine J McCleary; Jeffrey A Meyerhardt; Kimmie Ng; Al B Benson; Monica M Bertagnolli; Charles S Fuchs
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(3):890-900.
2012: Federico Innocenti; Chen Jiang; Hedy L Kindler; Michiaki Kubo; Liang Li; Howard L McLeod; Taisei Mushiroda; Yusuke Nakamura; Kouros Owzar; Nancy L Cox; Patrick Evans; Paula Friedman; Kathleen M Giacomini; Dylan Glubb; Richard M Goldberg; Donna Hollis; Herbert Hurwitz; Richard L Schilsky; Liewei Wang; Hitoshi Zembutsu; Mark J Ratain
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(2):577-84.
2012: Daniel J Sargent; Marc Buyse; Aimery de Gramont; Richard M Goldberg; Alastair Matheson
The ARCAD clinical trials program: an update and invitation.
The oncologist 2012;17(2):188-91.
2011: Amy S Lucas; Bert H O'Neil; Richard M Goldberg
A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancer.
Clinical colorectal cancer 2011;10(4):238-44.
2011: Benoist Chibaudel; Carmen J Allegra; Franck bonnetain; Marc Buyse; Richard M Goldberg; Daniel J Sargent; Qian Shi; Christophe Tournigand; Aimery de Gramont
Alternative end points to evaluate a therapeutic strategy in advanced colorectal cancer: evaluation of progression-free survival, duration of disease control, and time to failure of strategy--an Aide et Recherche en Cancerologie Digestive Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(31):4199-204.
2011: Greg Yothers; Jacqueline K Benedetti; A William Blackstock; James J Dignam; Richard M Goldberg; Michael J O'Connell; Leonard B Saltz; Daniel J Sargent; Norman Wolmark
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
Journal of the National Cancer Institute 2011;103(20):1498-506.
2011: Kimmie Ng; Donna Niedzwiecki; Shuji Ogino; Leonard B Saltz; Paul L Schaefer; Alan P Venook; Renaud Whittom; Al B Benson; Monica M Bertagnolli; Andrew T Chan; Jennifer A Chan; Richard M Goldberg; Alexander Hantel; Donna Hollis; Robert J Mayer; Jeffrey A Meyerhardt; Charles S Fuchs
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
Journal of the National Cancer Institute 2011;103(20):1540-51.
2011: Ming-Wen An; Megan E Branda; Richard M Goldberg; Shauna L Hillman; Sumithra J Mandrekar; Henry C Pitot; Alex A. Adjei; Daniel J Sargent
Comparison of continuous versus categorical tumor measurement-based metrics to predict overall survival in cancer treatment trials.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(20):6592-9.
2011: Monica M Bertagnolli; Thomas A Colacchio; Carolyn Corlies Compton; Richard M Goldberg; Robert J Mayer; Donna Niedzwiecki; Mark Redston; Leonard B Saltz; Robert S Warren
Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(23):3153-62.
2011: Donna Niedzwiecki; Mark O'Rourke; Michael C Perry; J Marc Pipas; Gity N Porjosh; Philippe Rougier; Joel H Schwartz; Robert S Warren; Steven Alberts; James Atkins; Al Bowen Benson; Monica M Bertagnolli; Carolyn Corlies Compton; S Gail Eckhardt; Anthony Fields; Richard M Goldberg; Nancy E Kemeny; David J Kerr; Robert J Mayer; Thomas A Colacchio
Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(23):3146-52.
2011: Janine M Davies; Richard M Goldberg
Treatment of metastatic colorectal cancer.
Seminars in oncology 2011;38(4):552-60.
2011: Bert H O'Neil; William K Funkhouser; Benjamin F Calvo; Michael O Meyers; Hong Jin Kim; Richard M Goldberg; Stephen A Bernard; Laura Caskey; Allison M Deal; Fred Wright; Albert S Baldwin; Joel E Tepper
Nuclear factor κ-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy.
International journal of radiation oncology, biology, physics 2011;80(3):705-11.
2011: Autumn J McRee; Richard M Goldberg
Optimal management of metastatic colorectal cancer: current status.
Drugs 2011;71(7):869-84.
2011: Kimmie Ng; Daniel J Sargent; Richard M Goldberg; Jeffrey A Meyerhardt; Erin M Green; Henry C Pitot; Bruce W Hollis; Michael N Pollak; Charles S Fuchs
Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(12):1599-606.
2011: Autumn J McRee; Stacy Cowherd; Andrew Zhuang Wang; Richard M Goldberg
Chemoradiation therapy in the management of gastrointestinal malignancies.
Future oncology (London, England) 2011;7(3):409-26.
2011: Charles D Blanke; Richard M Goldberg; Axel Grothey; Neal J Meropol; Margaret Mooney; Nancy Roach; Leonard B Saltz; John J Welch; William A Wood
KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practice.
The oncologist 2011;16(8):1061-8.
2011: James M Heun; Megan E Branda; Richard M Goldberg; Axel Grothey; Daniel J Sargent
Tumor status at 12 weeks predicts survival in advanced colorectal cancer: findings from NCCTG N9741.
The oncologist 2011;16(6):859-67.
2011: Carmen J Allegra; Greg Yothers; Michael J O'Connell; Saima Sharif; Nicholas J Petrelli; Linda H Colangelo; James N Atkins; Thomas E Seay; Louis Fehrenbacher; Richard M Goldberg; Seamus O'Reilly; Luis Chu; Catherine A Azar; Samia Lopa; Norman Wolmark
Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(1):11-6.
2010: Janine M Davies; Richard M Goldberg
Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases.
Journal of surgical oncology 2010;102(8):946-54.
2010: Kimmie Ng; Jeffrey A Meyerhardt; Jennifer A Chan; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Al B Benson; Paul L Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Charlie S Fuchs
Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(28):4354-63.
2010: Hedy L Kindler; Donna Niedzwiecki; Donna Hollis; Susan Sutherland; Deborah Schrag; Herbert Hurwitz; Federico Innocenti; Mary Frances Mulcahy; Eileen O'Reilly; Timothy F Wozniak; Joel Picus; Pankaj Bhargava; Robert J Mayer; Richard L Schilsky; Richard M Goldberg
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(22):3617-22.
2010: Howard L McLeod; Daniel J Sargent; Sharon Marsh; Erin M Green; Cristi R King; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Stephen N Thibodeau; Axel Grothey; Roscoe F Morton; Richard M Goldberg
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3227-33.
2010: Laura Raftery; Richard M Goldberg
Optimal delivery of cytotoxic chemotherapy for colon cancer.
Cancer journal (Sudbury, Mass.) 2010;16(3):214-9.
2010: Hui Tang; Nathan R Foster; Axel Grothey; Stephen M Ansell; Richard M Goldberg; Daniel J Sargent
Comparison of error rates in single-arm versus randomized phase II cancer clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(11):1936-41.
2010: Bert H O'Neil; Laura Raftery; Benjamin F Calvo; A Bapsi Chakravarthy; Anastasia Ivanova; Michael O Myers; Hong Jin Kim; Emily Chan; Paul E Wise; Laura S Caskey; Stephen A Bernard; Hanna Sanoff; Richard M Goldberg; Joel E Tepper
A phase I study of bortezomib in combination with standard 5-fluorouracil and external-beam radiation therapy for the treatment of locally advanced or metastatic rectal cancer.
Clinical colorectal cancer 2010;9(2):119-25.
2010: Hanna Sanoff; Richard M Goldberg; Michael Pignone
Assessing the quality of initial consultations regarding adjuvant colon cancer therapy.
Clinical colorectal cancer 2010;9(2):113-8.
2010: Nadine Jackson McCleary; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Paul Schaefer; Renaud Whittom; Alexander Hantel; Al Benson; Richard M Goldberg; Jeffrey A Meyerhardt
Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803.
Cancer 2010;116(4):957-66.
2010: Aimery de Gramont; Joleen Hubbard; Qian Shi; Michael J O'Connell; Marc Buyse; Jacqueline K Benedetti; Brian Bot; Chris O'Callaghan; Greg Yothers; Richard M Goldberg; Charles D Blanke; Al Benson; Qiqi Deng; Steven R Alberts; Thierry Andre; Norman Wolmark; Axel Grothey; Daniel Sargent
Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(3):460-5.
2010: Eileen M O'Reilly; Donna Niedzwiecki; Margaret Hall; Donna Hollis; Tanios Bekaii-Saab; Timothy Pluard; Kathe Douglas; Ghassan K Abou-Alfa; Hedy L Kindler; Richard L Schilsky; Richard M Goldberg
A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603).
The oncologist 2010;15(12):1310-9.
2010: Richard M Goldberg
Strategic options on behalf of patients with metastatic colorectal cancer: mass tumor murder versus serial tumor killing.
Onkologie 2010;33(6):291-2.
2010: Tejinder K Rakhra-Burris; Todd Auman; Patricia A Deverka; Lynn Dressler; James P Evans; Richard M Goldberg; Tammy M Havener; Janelle M Hoskins; Daniel Jonas; Kevin M Long; Alison A Motsinger-Reif; William Irvin; Kristy Richards; Mary Roederer; John M Valgus; Marcia van Riper; John Vernon; William C Zamboni; Michael J Wagner; Christine M Walko; Karen E Weck; Timothy Wiltshire; howard mcleod
Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care.
Pharmacogenomics 2010;11(1):13-21.
2009: Shuji Ogino; Jeffrey A Meyerhardt; Natsumi Irahara; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Paul Schaefer; Renaud Whittom; Alexander Hantel; Al B Benson; Richard M Goldberg; Monica M Bertagnolli; Charlie S Fuchs
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(23):7322-9.
2009: Matthew H Kulke; Margaret A Tempero; Donna Niedzwiecki; Donna R Hollis; Hedy L Kindler; Michael Cusnir; Peter C Enzinger; Stefan M Gorsch; Richard M Goldberg; Robert J Mayer
Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(33):5506-12.
2009: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Erin Green; Hanna Sanoff; howard mcleod; Jan Buckner
NCCTG Study N9741: leveraging learning from an NCI Cooperative Group phase III trial.
The oncologist 2009;14(10):970-8.
2009: Richard M Goldberg; Neal J Meropol; Josep Tabernero
Accomplishments in 2008 in the treatment of advanced metastatic colorectal cancer.
Gastrointestinal cancer research : GCR 2009;3(5 Supplement 2):S23-7.
2009: Richard M Goldberg; Bert O Neil
Colorectal cancer: Irinotecan therapy-following a trail of breadcrumbs?
Nature reviews. Gastroenterology & hepatology 2009;6(9):507-9.
2009: Hanna Sanoff; Daniel J Sargent; Erin M Green; howard mcleod; Richard M Goldberg
Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):4109-15.
2009: Carmen J Allegra; Greg Yothers; Michael J O'Connell; Saima Sharif; Linda H Colangelo; Samia H Lopa; Nicholas J Petrelli; Richard M Goldberg; James N Atkins; Thomas E Seay; Louis Fehrenbacher; Seamus O'Reilly; Luis Chu; Catherine A Azar; Norman Wolmark
Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):3385-90.
2009: Sharlene Gill; Richard M Goldberg
Cetuximab, chemotherapy and KRAS status in mCRC.
Nature reviews. Clinical oncology 2009;6(7):379-80.
2009: Shauna L Hillman; Ming-Wen An; Michael J O'Connell; Richard M Goldberg; Paul Schaefer; Jan C Buckner; Daniel J Sargent
Evaluation of the optimal number of lesions needed for tumor evaluation using the response evaluation criteria in solid tumors: a north central cancer treatment group investigation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(19):3205-10.
2009: George P Kim; Daniel J Sargent; Michelle R Mahoney; Kendrith M Rowland; Philip A Philip; Edith Mitchell; Abraham P Mathews; Tom R Fitch; Richard M Goldberg; Steven R Alberts; Henry C Pitot
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2848-54.
2009: Yu-Ning Wong; Neal J Meropol; William Speier; Daniel Sargent; Richard M Goldberg; J Robert Beck
Cost implications of new treatments for advanced colorectal cancer.
Cancer 2009;115(10):2081-91.
2009: Daniel J Sargent; Claus-Henning Köhne; Hanna Sanoff; Brian M Bot; Matthew T Seymour; Aimery de Gramont; Ranier Porschen; Leonard B Saltz; Philippe Rougier; Christophe Tournigand; Jean-Yves Douillard; Richard J Stephens; Axel Grothey; Richard M Goldberg
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(12):1948-55.
2009: Monica M Bertagnolli; Donna Niedzwiecki; Carolyn Corlies Compton; Hejin P Hahn; Margaret Hall; Beatrice Damas; Scott D Jewell; Robert J Mayer; Richard M Goldberg; Leonard B Saltz; Robert S Warren; Mark Redston
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1814-21.
2009: Grace K Dy; Timothy J Hobday; Garth Nelson; Harold E Windschitl; Michael J O'Connell; Steven R Alberts; Richard M Goldberg; Daniel A Nikcevich; Daniel J Sargent
Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a North Central Cancer Treatment Group review of 3811 patients, N0144.
Clinical colorectal cancer 2009;8(2):88-93.
2009: Monica M Bertagnolli; Robert S Warren; Donna Niedzwiecki; Elke Mueller; Carolyn Corlies Compton; Mark Redston; Margaret Hall; Hejin P Hahn; Scott D Jewell; Robert J Mayer; Richard M Goldberg; Leonard B Saltz; Massimo Loda
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2116-22.
2009: Usman Shah; Bert O Neil; Jill Allen; Richard M Goldberg; Stephen A Bernard; Dominic Moore; Alan P Venook; Michael M Morse
A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or Higher.
Gastrointestinal cancer research : GCR 2009;3(2):45-8.
2009: Daniel Sargent; Alberto Sobrero; Axel Grothey; Michael J O'Connell; Marc Buyse; Thierry Andre; Yan Zheng; Erin Green; Roberto Labianca; Chris O'Callaghan; Jean Francois Seitz; Guido Francini; Daniel Haller; Greg Yothers; Richard M Goldberg; Aimery de Gramont
Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(6):872-7.
2009: Anthony J Cmelak; Florian Lordick; Markus Borner; Richard M Goldberg; M Wasif Saif
Management of infusion reactions in clinical trials and beyond: the US and EU perspectives.
Oncology (Williston Park, N.Y.) 2009;23(2 Suppl 1):18-25.
2009: Anthony J Cmelak; Richard M Goldberg
Infusion reactions associated with monoclonal antibodies in patients with solid tumors. Introduction.
Oncology (Williston Park, N.Y.) 2009;23(2 Suppl 1):5-6.
2009: William A Wood; Mary S McCabe; Richard M Goldberg
Commentary: Disclosure in oncology -- to whom does the truth belong?
The oncologist 2009;14(1):77-82.
2009: Sarah R McWhinney; Richard M Goldberg; howard mcleod
Platinum neurotoxicity pharmacogenetics.
Molecular cancer therapeutics 2009;8(1):10-6.
2009: Bert O Neil; Richard M Goldberg
What is the standard chemotherapy for colorectal cancer patients with resectable liver metastases?
Nature clinical practice. Oncology 2009;6(1):14-6.
2008: Charles S Fuchs; Richard M Goldberg; Daniel J Sargent; Jeffrey A Meyerhardt; Brian M Wolpin; Erin M Green; Henry C Pitot; Michael Pollak
Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(24):8263-9.
2008: Hanna Sanoff; Daniel J Sargent; Megan E Campbell; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Richard M Goldberg
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5721-7.
2008: Laura Raftery; Hanna Sanoff; Richard M Goldberg
Colon cancer in older adults.
Seminars in oncology 2008;35(6):561-8.
2008: Janine M Davies; Richard M Goldberg
First-line therapeutic strategies in metastatic colorectal cancer.
Oncology (Williston Park, N.Y.) 2008;22(13):1470-9.
2008: Bert O Neil; Richard M Goldberg
Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
The oncologist 2008;13(10):1074-83.
2008: Usman Shah; Richard M Goldberg
Sequential versus combination therapy in the treatment of patients with advanced colorectal cancer.
Clinical colorectal cancer 2008;7(5):315-20.
2008: Neal J Meropol; Donna Niedzwiecki; Brenda Shank; Thomas A Colacchio; John Ellerton; Frank Valone; Susan Budinger; Jeannette M Day; Judy Hopkins; Joel E Tepper; Richard M Goldberg; Robert J Mayer
Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3229-34.
2008: Abigail S Caudle; Hong Jin Kim; Joel E Tepper; Bert O Neil; Leslie A Lange; Richard M Goldberg; Stephen A Bernard; Benjamin F Calvo; Michael O Meyers
Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer.
Annals of surgical oncology 2008;15(7):1931-6.
2008: Jennifer A Chan; Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James P Thomas; Paul Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Robert S Warren; Monica Bertagnolli; Charlie S Fuchs
Association of family history with cancer recurrence and survival among patients with stage III colon cancer.
JAMA : the journal of the American Medical Association 2008;299(21):2515-23.
2008: Eric Van Cutsem; Mario Dicato; Karin Haustermans; N Arber; J-F Bosset; D Cunningham; A De Gramont; E Diaz-Rubio; M Ducreux; Richard M Goldberg; R Glynne-Jones; D Haller; Y-K Kang; D Kerr; R Labianca; B Minsky; M Moore; Bernard Nordlinger; Philippe Rougier; W Scheithauer; HJ Schmoll; Alberto Sobrero; Josep Tabernero; M Tempero; C Van de Velde; J Zalcberg
The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 6():vi1-8.
2008: Amy J French; Daniel J Sargent; Lawrence J Burgart; Nathan R Foster; Brian F Kabat; Richard M Goldberg; Lois E Shepherd; Harold E Windschitl; Stephen N Thibodeau
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3408-15.
2008: Michael J O'Connell; Megan E Campbell; Richard M Goldberg; Axel Grothey; Jean-François Seitz; Jacqueline K Benedetti; Thierry André; Daniel G Haller; Daniel J Sargent
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(14):2336-41.
2008: Richard M Goldberg; Alfredo Carrato
Accomplishments in 2007 in the treatment of advanced colorectal cancer.
Gastrointestinal cancer research : GCR 2008;2(3 Suppl):S19-24.
2008: Richard M Goldberg
As Federal Funding for Cancer is Cut, Researchers Struggle.
Gastrointestinal cancer research : GCR 2008;2(3):165.
2008: Thomas E Stinchcombe; Mark A Socinski; Carrie B Lee; David Hayes; Dominic T Moore; Richard M Goldberg; Elizabeth Dees
Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(5):521-6.
2008: Claus-Henning Köhne; Gunnar Folprecht; Richard M Goldberg; Emmanuel Mitry; Philippe Rougier
Chemotherapy in elderly patients with colorectal cancer.
The oncologist 2008;13(4):390-402.
2008: Joel E Tepper; Mark J Krasna; Donna Niedzwiecki; Donna Hollis; Carolyn E Reed; Richard M Goldberg; Krystyna Kiel; Christopher G Willett; David Sugarbaker; Robert Mayer
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(7):1086-92.
2008: Axel Grothey; Eric E Hedrick; Robert D Mass; Somnath Sarkar; Sam Suzuki; Ramesh K Ramanathan; Herbert I Hurwitz; Richard M Goldberg; Daniel J Sargent
Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):183-9.
2008: Usman Shah; Richard M Goldberg
Dealing With Discordance: Managing a Case Where the Patient Looks Better and the CT Scan Looks Worse.
Gastrointestinal cancer research : GCR 2008;2(1):45-6.
2008: Jane L Yen-Revollo; Richard M Goldberg; howard mcleod
Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines?
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):8-13.
2008: Mitchell C Posner; Donna Niedzwiecki; Alan P Venook; Donna R Hollis; Hedy L Kindler; Edward W Martin; Richard L Schilsky; Richard M Goldberg; Robert J Mayer
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
Annals of surgical oncology 2008;15(1):158-64.
2007: Richard M Goldberg; John L Marshall; Jaffer A Ajani; Philip A Philip; Eileen O'Reilly; Alan P Venook
Section IV: Significance of Recent Study Results and Future Research Directions in Gastrointestinal Oncology.
Gastrointestinal cancer research : GCR 2007;1(6 Suppl):S13-6.
2007: Richard M Goldberg; John L Marshall; Lisa A Kachnic; Alan P Venook
Section I: essentials of ensuring excellence in cancer care.
Gastrointestinal cancer research : GCR 2007;1(6 Suppl):S1-3.
2007: Hanna Sanoff; Richard M Goldberg
Colorectal cancer treatment in older patients.
Gastrointestinal cancer research : GCR 2007;1(6):248-53.
2007: Hanna Sanoff; Richard M Goldberg; Michael Pignone
A systematic review of the use of quality of life measures in colorectal cancer research with attention to outcomes in elderly patients.
Clinical colorectal cancer 2007;6(10):700-9.
2007: Daniel J Sargent; Smitha Patiyil; Greg Yothers; Daniel G Haller; Richard Gray; Jacqueline K Benedetti; Marc Buyse; Roberto Labianca; Jean Francois Seitz; Christopher J O'Callaghan; Guido Francini; Axel Grothey; Michael O'Connell; Paul J Catalano; David Kerr; Erin Green; H Samuel Wieand; Richard M Goldberg; Aimery de Gramont
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4569-74.
2007: Thomas E Stinchcombe; Mark A Socinski; Christine M Walko; Bert O Neil; Frances A Collichio; Anastasia Ivanova; Hua Mu; Michael J Hawkins; Richard M Goldberg; Celeste Lindley; E Claire Dees
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumors.
Cancer chemotherapy and pharmacology 2007;60(5):759-66.
2007: Janelle Hoskins; Richard M Goldberg; Pingping Qu; Joseph G Ibrahim; howard mcleod
UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters.
Journal of the National Cancer Institute 2007;99(17):1290-5.
2007: Bert O Neil; Robert Allen; David R Spigel; Thomas E Stinchcombe; Dominic T Moore; Jordan D Berlin; Richard M Goldberg
High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3644-8.
2007: Carmen Allegra; Charles D Blanke; Marc Buyse; Richard M Goldberg; Axel Grothey; Neal J Meropol; Leonard B Saltz; Alan P Venook; Greg Yothers; Daniel Sargent
End points in advanced colon cancer clinical trials: a review and proposal.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3572-5.
2007: Grace K Dy; James E Krook; Erin M Green; Daniel J Sargent; Thierry Delaunoit; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Barbara A Pockaj; Robert P Sticca; Steven R Alberts; Henry C Pitot; Richard M Goldberg
Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3469-74.
2007: Leonard B Saltz; Donna Niedzwiecki; Donna Hollis; Richard M Goldberg; Alexander Hantel; James P Thomas; Anthony L A Fields; Robert J Mayer
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3456-61.
2007: Amanda C Ashley; Daniel J Sargent; Steven R Alberts; Axel Grothey; Megan E Campbell; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Richard M Goldberg
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.
Cancer 2007;110(3):670-7.
2007: John L Marshall; Daniel G Haller; Aimery de Gramont; Howard S Hochster; Heinz-Josef Lenz; Jaffer A Ajani; Richard M Goldberg
Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology.
Gastrointestinal cancer research : GCR 2007;1(4):146-54.
2007: Steven R Alberts; George P Kim; Michelle R Mahoney; Michael K Gornet; Joseph Rubin; Matthew Ames; Matthew P Goetz; Richard M Weinshilboum; Steven J Nicol; Richard M Goldberg
Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248.
Clinical colorectal cancer 2007;6(8):572-7.
2007: Johanna C Bendell; Richard M Goldberg
Targeted agents in the treatment of pancreatic cancer: history and lessons learned.
Current opinion in oncology 2007;19(4):390-5.
2007: Bert O Neil; Richard M Goldberg
Should gemcitabine be used as adjuvant chemotherapy in patients with resectable pancreatic cancer?
Nature clinical practice. Gastroenterology & hepatology 2007;4(7):362-3.
2007: Hanna Sanoff; Harry Bleiberg; Richard M Goldberg
Managing older patients with colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(14):1891-7.
2007: Bert O Neil; Richard M Goldberg
On the state of the art of adjuvant chemotherapy for colon cancer.
Gastrointestinal cancer research : GCR 2007;1(3):115-7.
2007: Alan P Venook; Charles D Blanke; Donna Niedzwiecki; Heinz-Josef Lenz; John R Taylor; Donna R Hollis; Susan Sutherland; Richard M Goldberg
Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.
Clinical colorectal cancer 2007;6(7):536-8.
2007: Frank A Sinicrope; Rafaela L Rego; Megan M Garrity-Park; Nathan R Foster; Daniel J Sargent; Richard M Goldberg; Martin Wiesenfeld; Thomas E Witzig; Stephen N Thibodeau; Lawrence J Burgart
Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability.
International journal of cancer. Journal international du cancer 2007;120(6):1232-8.
2007: Richard M Goldberg
Which strategies will lead to progress in the management of colorectal cancer?
Gastrointestinal cancer research : GCR 2007;1(4 Suppl 2):S33-6.
2007: Bert O Neil; Petra Bůzková; Hillary Farrah; David Kashatus; Hanna Sanoff; Richard M Goldberg; Albert S Baldwin; William K Funkhouser
Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas.
Oncology 2007;72(1-2):97-104.
2007: Matthew R Skelton; Richard M Goldberg; Bert O Neil
A case of oxaliplatin-related posterior reversible encephalopathy syndrome.
Clinical colorectal cancer 2007;6(5):386-8.
2007: Sharlene Gill; A. William Blackstock; Richard M Goldberg
Colorectal cancer.
Mayo Clinic proceedings. Mayo Clinic 2007;82(1):114-29.
2007: Richard M Goldberg; Mace L Rothenberg; Eric Van Cutsem; Al B Benson; Charles D Blanke; Robert B Diasio; Axel Grothey; Heinz-Josef Lenz; Neal J Meropol; Ramesh K Ramanathan; Carlos H Roberto Becerra; Rita Wickham; Delma Armstrong; Carol Viele
The continuum of care: a paradigm for the management of metastatic colorectal cancer.
The oncologist 2007;12(1):38-50.
2007: Ajay Goel; Takeshi Nagasaka; Christian N Arnold; Toru Inoue; Cody Hamilton; Donna Niedzwiecki; Carolyn Corlies Compton; Robert J Mayer; Richard M Goldberg; Monica M Bertagnolli; C Richard Boland
The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Gastroenterology 2007;132(1):127-38.
2006: Dhavalkumar D Patel; Richard M Goldberg
Cetuximab-associated infusion reactions: pathology and management.
Oncology (Williston Park, N.Y.) 2006;20(11):1373-82; discussion 1382, 1392-4, 1397.
2006: Richard M Goldberg
Therapy for metastatic colorectal cancer.
The oncologist 2006;11(9):981-7.
2006: Frank A Sinicrope; Rafaela L Rego; Kevin C Halling; Nathan Foster; Daniel J Sargent; Betsy La Plant; Amy J French; John A Laurie; Richard M Goldberg; Stephen N Thibodeau; Thomas E Witzig
Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.
Gastroenterology 2006;131(3):729-37.
2006: Richard M Goldberg; Isabelle Tabah-Fisch; Harry Bleiberg; Aimery de Gramont; Christophe Tournigand; Thierry Andre; Mace L Rothenberg; Erin Green; Daniel J Sargent
Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4085-91.
2006: Richard M Goldberg; Herbert I Hurwitz; Charlie S Fuchs
The role of targeted therapy in the treatment of colorectal cancer.
Clinical advances in hematology & oncology : H&O 2006;4(8 Suppl 17):1-10; quiz 11-2.
2006: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven Alberts
Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3347-53.
2006: Larry J Schaaf; Lisa A Hammond; Stuart J Tipping; Richard M Goldberg; Rakesh Goel; John Kuhn; Langdon L Miller; Linda D Compton; Laura A Cisar; Gary L Elfring; Gabriela Gruia; J Patrick McGovren; Nicoletta Pirotta; Donghua Yin; Amarnath Sharma; Barbara A Duncan; Mace L Rothenberg
Phase 1 and pharmacokinetic study of intravenous irinotecan in refractory solid tumor patients with hepatic dysfunction.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(12):3782-91.
2006: Eric Van Cutsem; Mario Dicato; N Arber; A Benson; D Cunningham; E Diaz-Rubio; Bengt Glimelius; Richard M Goldberg; D Haller; Karin Haustermans; Y Koo-Kang; R Labianca; I Lang; B Minsky; Bernard Nordlinger; A Roth; Philippe Rougier; HJ Schmoll; Alberto Sobrero; Josep Tabernero; A Szawlowski; C van de Velde
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 6():vi13-8.
2006: Richard M Goldberg; Donna Niedzwiecki; Monica M Bertagnolli; A. William Blackstock; Joel E Tepper; Robert J Mayer
Cancer and leukemia group B gastrointestinal cancer committee.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 2):3589s-95s.
2006: David P Ryan; Donna Niedzwiecki; Donna Hollis; Brent E Mediema; Scott Wadler; Joel E Tepper; Richard M Goldberg; Robert J Mayer
Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2557-62.
2006: Frank A Sinicrope; Rafaela L Rego; Kevin C Halling; Nathan R Foster; Daniel J Sargent; Betsy La Plant; Amy J French; Carmen J Allegra; John A Laurie; Richard M Goldberg; Thomas E Witzig; Stephen N Thibodeau
Thymidylate synthase expression in colon carcinomas with microsatellite instability.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2738-44.
2006: Anne W Beaven; Richard M Goldberg
Adjuvant therapy for colorectal cancer: yesterday, today, and tomorrow.
Oncology (Williston Park, N.Y.) 2006;20(5):461-9; discussion 469-70, 473-5.
2006: Thierry Delaunoit; Paul J Limburg; Richard M Goldberg; James F Lymp; Edward V Loftus
Colorectal cancer prognosis among patients with inflammatory bowel disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(3):335-42.
2006: Richard M Goldberg
Intensive surveillance after stage II or III colorectal cancer: is it worth it?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):330-1.
2005: Michelle R Mahoney; Daniel J Sargent; Michael J O'Connell; Richard M Goldberg; Paul Schaefer; Jan C Buckner
Dealing with a deluge of data: an assessment of adverse event data on North Central Cancer Treatment Group trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9275-81.
2005: Steven R Alberts; William L Horvath; William C Sternfeld; Richard M Goldberg; Michelle R Mahoney; Shaker R Dakhil; Ralph Levitt; Kendrith M Rowland; Suresh Nair; Daniel J Sargent; John H Donohue
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9243-9.
2005: Richard M Goldberg; Herbert I Hurwitz; Charlie S Fuchs
Angiogenesis inhibition in the treatment of colorectal cancer Part 3 of a 3-part series: targeting VEGF--current and future research directions.
Clinical advances in hematology & oncology : H&O 2005;3(12):1-10; quiz 11.
2005: Daniel J Sargent; H Samuel Wieand; Daniel G Haller; Richard Gray; Jacqueline K Benedetti; Marc Buyse; Roberto Labianca; Jean Francois Seitz; Christopher J O'Callaghan; Guido Francini; Axel Grothey; Michael O'Connell; Paul J Catalano; Charles D Blanke; David Kerr; Erin Green; Norman Wolmark; Thierry Andre; Richard M Goldberg; Aimery de Gramont
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8664-70.
2005: S P Ackland; M Jones; D Tu; R John Simes; J Yuen; A-M Sargeant; Haryana Dhillon; Richard M Goldberg; Ehtesham A Abdi; L Shepherd; M J Moore
A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer.
British journal of cancer 2005;93(11):1236-43.
2005: Alan P Venook; Charles D Blanke; Donna Niedzwiecki; Heinz-Josef Lenz; John R Taylor; Donna R Hollis; Susan Sutherland; Richard M Goldberg
Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma.
Clinical colorectal cancer 2005;5(4):292-4.
2005: bruce hillner; Deborah Schrag; Daniel J Sargent; Charlie S Fuchs; Richard M Goldberg
Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma.
Cancer 2005;104(9):1871-84.
2005: Sharlene Gill; Noralane M Lindor; Lawrence J Burgart; Regenia Smalley; Olga Leontovich; Amy J French; Richard M Goldberg; Daniel J Sargent; Jeremy R Jass; John L Hopper; Mark A Jenkins; Joanne Young; Melissa A Barker; Michael D Walsh; Andrew Ruszkiewicz; Stephen N Thibodeau
Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6466-71.
2005: Hanna Sanoff; Richard M Goldberg
Systemic therapy for metastatic colorectal cancer: current options, current evidence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(20):4553-60.
2005: Sharlene Gill; Richard M Goldberg
Duration of adjuvant therapy for colorectal cancer: are we overtreating our patients?
Nature clinical practice. Oncology 2005;2(6):276-7.
2005: Jeffrey A Meyerhardt; Jeffrey A Sloan; Daniel J Sargent; Richard M Goldberg; Michael Pollak; Roscoe F Morton; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Charlie S Fuchs
Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1402-10.
2005: Richard M Goldberg
Lessons learned from the edrecolomab story: how a checkered past became a checkered flag for monoclonal antibodies in colorectal cancer therapy.
Onkologie 2005;28(6-7):311-2.
2005: Grace K Dy; Ajit Suri; Joel M Reid; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Pamela J Atherton; Lorelei J Hanson; Patrick A Burch; Joseph Rubin; Charles Erlichman; Alex A. Adjei
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2005;55(6):522-30.
2005: Richard M Goldberg
Cetuximab.
Nature reviews. Drug discovery 2005;Suppl():S10-1.
2005: Noralane M Lindor; Kari Rabe; Gloria M Petersen; Robert W Haile; Graham Casey; John Baron; Steven Gallinger; Bharati Bapat; Melyssa Aronson; John Hopper; Jeremy Jass; Loic LeMarchand; John Grove; John Potter; Polly Newcomb; Jonathan P Terdiman; Peggy Conrad; Gabriella Moslein; Richard M Goldberg; Argyrios Ziogas; Hoda Anton-Culver; Mariza de Andrade; Kimberly D Siegmund; Stephen N Thibodeau; Lisa A Boardman; Daniela Seminara
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
JAMA : the journal of the American Medical Association 2005;293(16):1979-85.
2005: Elizabeth A Poplin; Jacqueline K Benedetti; Norman C. Estes; Daniel G Haller; Robert J Mayer; Richard M Goldberg; Geoffrey R Weiss; Saul E Rivkin; John S Macdonald
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1819-25.
2005: Joel E Tepper; Richard M Goldberg
An embarrassment of riches: neoadjuvant therapy of rectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(7):1339-41.
2005: Thierry Delaunoit; Steven R Alberts; Daniel J Sargent; Erin Green; Richard M Goldberg; James E Krook; C Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Roscoe F Morton; Brian P Findlay
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(3):425-9.
2005: Bert O Neil; Richard M Goldberg
Chemotherapy for advanced colorectal cancer: let's not forget how we got here (until we really can).
Seminars in oncology 2005;32(1):35-42.
2005: Richard M Goldberg
Advances in the treatment of metastatic colorectal cancer.
The oncologist 2005;10 Suppl 3():40-8.
2005: Stacy D'Andre; Daniel J Sargent; Stephen S Cha; Thomas R Buroker; John W Kugler; Richard M Goldberg; Michael J O'Connell; Michael A Poon
5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study.
Clinical colorectal cancer 2005;4(5):325-31.
2004: Thierry Delaunoit; Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Brian P Findlay; Sachdev P Thomas; Muhammad Salim; Paul L Schaefer; Philip J Stella; Erin Green; James A Mailliard
Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.
Cancer 2004;101(10):2170-6.
2004: Richard M Goldberg; Alan P Venook; Richard L Schilsky
Cetuximab in the treatment of colorectal cancer.
Clinical advances in hematology & oncology : H&O 2004;2(11):1-10; quiz 11-12.
2004: Shannon K Penland; Richard M Goldberg
Combining anti-VEGF approaches with oxaliplatin in advanced colorectal cancer.
Clinical colorectal cancer 2004;4 Suppl 2():S74-80.
2004: Axel Grothey; Richard M Goldberg
A review of oxaliplatin and its clinical use in colorectal cancer.
Expert opinion on pharmacotherapy 2004;5(10):2159-70.
2004: Richard M Goldberg; Sharlene Gill
Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancer.
Cancer chemotherapy and pharmacology 2004;54 Suppl 1():S57-64.
2004: James A Martenson; Christopher G Willett; Daniel J Sargent; James A Mailliard; John H Donohue; Leonard L Gunderson; Charles Thomas; Barbara Fisher; Al B Benson; Robert J Myerson; Richard M Goldberg
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(16):3277-83.
2004: Richard M Goldberg
Current approaches to first-line treatment of advanced colorectal cancer.
Clinical colorectal cancer 2004;4 Suppl 1():S9-15.
2004: Sharlene Gill; Charles L Loprinzi; Daniel J Sargent; Stephan D Thomé; Steven R Alberts; Daniel G Haller; Jacqueline K Benedetti; Guido Francini; Lois E Shepherd; Jean Francois Seitz; Roberto Labianca; Wei Chen; Stephen S Cha; Michael P Heldebrant; Richard M Goldberg
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(10):1797-806.
2004: Leonard L Gunderson; Daniel J Sargent; Joel E Tepper; Norman Wolmark; Michael J O'Connell; Mirsada Begovic; Cristine Allmer; Linda H Colangelo; Steven R Smalley; Daniel G Haller; James A Martenson; Robert J Mayer; tyvin rich; Jaffer A Ajani; John S Macdonald; Christopher G Willett; Richard M Goldberg
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(10):1785-96.
2004: Shannon K Penland; Richard M Goldberg
Current strategies in previously untreated advanced colorectal cancer.
Oncology (Williston Park, N.Y.) 2004;18(6):715-22, 727; discussion 727-9.
2004: Megan M Garrity; Lawrence J Burgart; Michelle R Mahoney; Harold E Windschitl; Muhammad Salim; Martin Wiesenfeld; James E Krook; John C Michalak; Richard M Goldberg; Michael J O'Connell; Alfred F Furth; Daniel J Sargent; Linda M Murphy; Eunice Hill; Darren L Riehle; Cecelia H Meyers; Thomas E Witzig
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1572-82.
2004: Axel Grothey; Daniel Sargent; Richard M Goldberg; Hans-Joachim Schmoll
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1209-14.
2004: Noralane M Lindor; Jeff Sloan; Richard M Goldberg; Deborah Bowen; Sandra Nigon; Amber Roche; Gloria Petersen; Stephen N Thibodeau; Laurence Burgart; Olga Leontovich; Bruce W Morlan
Colorectal tumour microsatellite instability test results: perspectives from patients.
Hereditary cancer in clinical practice 2004;2(2):69-75.
2004: Jennifer A Egan; Nicholas Bandarenko; Shauna Hay; Linda Paradowski; Richard M Goldberg; Volker Nickeleit; Mark E Brecher
Differentiating thrombotic microangiopathies induced by severe hypertension from anemia and thrombocytopenia seen in thrombotic thrombocytopenia purpura.
Journal of clinical apheresis 2004;19(3):125-9.
2004: Sharlene Gill; Richard M Goldberg
First-line treatment strategies to improve survival in patients with advanced colorectal cancer.
Drugs 2004;64(1):27-44.
2004: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven R Alberts
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):23-30.
2003: Bert O Neil; Richard M Goldberg
Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived.
Expert opinion on investigational drugs 2003;12(12):1939-49.
2003: Matthew P Goetz; Charles Erlichman; Anthony J Windebank; Joel M Reid; Jeff A Sloan; Pamela J Atherton; Alex A. Adjei; Joseph Rubin; Henry C Pitot; Evanthia C Galanis; Matthew M Ames; Richard M Goldberg
Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3761-9.
2003: Gul Atalay; Fatima Cardoso; Marianne Paesmans; Richard M Goldberg; H Bleiberg
Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice?
Anti-cancer drugs 2003;14(9):703-13.
2003: S Gill; R R Thomas; Richard M Goldberg
Review article: colorectal cancer chemotherapy.
Alimentary pharmacology & therapeutics 2003;18(7):683-92.
2003: Sharlene Gill; Rebecca R Thomas; Richard M Goldberg
New targeted therapies in gastrointestinal cancers.
Current treatment options in oncology 2003;4(5):393-403.
2003: Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
The New England journal of medicine 2003;349(3):247-57.
2003: Alex A. Adjei; Gary A Croghan; Charles Erlichman; Randolph S Marks; Joel M Reid; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Laura M Bruzek; Pamela J Atherton; Alain Thibault; Peter A Palmer; Scott H Kaufmann
A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2520-6.
2003: Al B Benson; Richard M Goldberg
Optimal use of the combination of irinotecan and 5-fluorouracil.
Seminars in oncology 2003;30(3 Suppl 6):68-77.
2003: Sharlene Gill; Richard M Goldberg
New developments in therapy for colorectal cancer.
Current oncology reports 2003;5(3):183-91.
2003: James A Martenson; Antonio P G Vigliotti; Henry C Pitot; Louis H Geeraerts; Daniel J Sargent; Michael G Haddock; Chirantan Ghosh; Michael D Keppen; Tom R Fitch; Richard M Goldberg
A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer.
International journal of radiation oncology, biology, physics 2003;55(5):1305-10.
2003: Steven R Alberts; P M Townley; Richard M Goldberg; S S Cha; Daniel J Sargent; Dennis F Moore; James E Krook; Henry C Pitot; Tom R Fitch; Martin Wiesenfeld; James A Mailliard
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):580-5.
2003: Sanjay Kakar; Lawrence J Burgart; Stephen N Thibodeau; Kari G Rabe; Gloria M Petersen; Richard M Goldberg; Noralane M Lindor
Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age.
Cancer 2003;97(6):1421-7.
2003: Richard M Goldberg
Evolving therapy and management of metastatic colon cancer.
Clinical advances in hematology & oncology : H&O 2003;1(3):159-60.
2003: Alex A. Adjei; Grace K Dy; Charles Erlichman; Joel M Reid; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Pamela J Atherton; Tanya Watanabe; Richard S Geary; Jon T Holmlund; F Andrew Dorr
A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):115-23.
2002: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Michelle R Mahoney; James E Krook; Michael J O'Connell
Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4591-6.
2002: Timothy J Hobday; John W Kugler; Michelle R Mahoney; Daniel J Sargent; Jeff A Sloan; Tom R Fitch; James E Krook; Michael J O'Connell; James A Mailliard; Maria Tria Tirona; Loren K Tschetter; Charles D Cobau; Richard M Goldberg
Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4574-80.
2002: Timothy J Hobday; Richard M Goldberg
Perspectives on the role of sequential or combination chemotherapy for first-line and salvage therapy in advanced colorectal cancer.
Clinical colorectal cancer 2002;2(3):161-9.
2002: Richard M Goldberg; Scott H Kaufmann; Pamela J Atherton; Jeff A Sloan; Alex A. Adjei; Henry C Pitot; Steven R Alberts; Joseph Rubin; L L Miller; Charles Erlichman
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(10):1674-80.
2002: Leonard L Gunderson; Daniel J Sargent; Joel E Tepper; Michael J O'Connell; Cristine Allmer; Steven R Smalley; James A Martenson; Daniel G Haller; Robert J Mayer; tyvin rich; Jaffer A Ajani; John S Macdonald; Richard M Goldberg
Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.
International journal of radiation oncology, biology, physics 2002;54(2):386-96.
2002: Richard M Goldberg
N9741: a phase III study comparing irinotecan to oxaliplatin-containing regimens in advanced colorectal cancer.
Clinical colorectal cancer 2002;2(2):81.
2002: Alex A. Adjei; Joel M Reid; Charles Erlichman; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Stacie Ruben; Scott A Boemer; Pamela J Atherton; Matthew M Ames; Scott H Kaufmann
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer.
Investigational new drugs 2002;20(3):297-304.
2002: Steven R Alberts; P M Townley; Richard M Goldberg; S S Cha; Dennis F Moore; James E Krook; Henry C Pitot; Tom R Fitch; Martin Wiesenfeld; James A Mailliard; Daniel J Sargent
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(4):553-7.
2002: Carmen J Allegra; Allyson L Parr; Lester E Wold; Michelle R Mahoney; Daniel J Sargent; Patrick Johnston; Pamela Klein; Katie Behan; Michael J O'Connell; Ralph Levitt; John W Kugler; Maria Tria Tirona; Richard M Goldberg
Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1735-43.
2002: Alex A. Adjei; Joel M Reid; Robert B Diasio; Jeff A Sloan; Deborah A Smith; Joseph Rubin; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Pamela J Atherton; Matthew M Ames; Charles Erlichman
Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1683-91.
2002: Jeff A Sloan; Richard M Goldberg; Daniel J Sargent; Delfino Vargas-Chanes; Suresh Nair; Stephen S Cha; Paul J Novotny; Michael A Poon; Michael J O'Connell; Charles L Loprinzi
Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1491-8.
2002: Henry C Pitot; Joel M Reid; Jeff A Sloan; Matthew M Ames; Alex A. Adjei; Joseph Rubin; Pamela G Bagniewski; Pamela J Atherton; Daniel Rayson; Richard M Goldberg; Charles Erlichman
A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(3):712-7.
2002: Noralane M Lindor; Lawrence J Burgart; Olga Leontovich; Richard M Goldberg; Julie M Cunningham; Daniel J Sargent; Catherine Walsh-Vockley; Gloria M Petersen; Michael D Walsh; Barbara A Leggett; Joanne P Young; Melissa A Barker; Jeremy R Jass; John Hopper; Steven Gallinger; Bharati Bapat; Mark Redston; Stephen N Thibodeau
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):1043-8.
2002: Aminah Jatoi; Maria Tria Tirona; Stephen S Cha; Steven R Alberts; Kendrith M Rowland; Roscoe F Morton; Suresh Nair; Carl G Kardinal; Philip J Stella; James A Mailliard; Daniel Sargen; Richard M Goldberg
A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia.
International journal of gastrointestinal cancer 2002;32(2-3):115-23.
2002: Steven R Alberts; Paul A. Fishkin; Lawrence J Burgart; Peter J Cera; Michelle R Mahoney; Roscoe F Morton; Patricia A Johnson; Suresh Nair; Richard M Goldberg
CPT-11 for bile-duct and gallbladder carcinoma: a phase II North Central Cancer Treatment Group (NCCTG) study.
International journal of gastrointestinal cancer 2002;32(2-3):107-14.
2001: Daniel J Sargent; Richard M Goldberg; S D Jacobson; J S Macdonald; Roberto Labianca; Daniel G Haller; L E Shepherd; J F Seitz; Guido Francini
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.
The New England journal of medicine 2001;345(15):1091-7.
2001: Evanthia C Galanis; Richard M Goldberg; J Reid; Pamela J Atherton; J Sloan; Henry C Pitot; Joseph Rubin; Alex A. Adjei; P Burch; Stephanie L Safgren; T E Witzig; Matthew M Ames; Charles Erlichman
Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):701-7.
2001: Steven R Alberts; Charles Erlichman; J Sloan; S H Okuno; Patrick A Burch; Joseph Rubin; Henry C Pitot; Richard M Goldberg; Alex A. Adjei; Pamela J Atherton; S H Kaufmann
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):627-31.
2001: D J Sargent; Richard M Goldberg
A flexible design for multiple armed screening trials.
Statistics in medicine 2001;20(7):1051-60.
2001: D J Sargent; V Chan; Richard M Goldberg
A three-outcome design for phase II clinical trials.
Controlled clinical trials 2001;22(2):117-25.
2001: Charles Erlichman; Alex A. Adjei; Steven R Alberts; Jeff A Sloan; Richard M Goldberg; Henry C Pitot; Joseph Rubin; Pamela J Atherton; G G Klee; R Humphrey
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):389-95.
2001: H C Pitot; Richard M Goldberg
Future directions in adjuvant therapy for stage III colon carcinoma.
Oncology (Williston Park, N.Y.) 2001;15(3 Suppl 5):31-6.
2001: Shaji Kumar; Richard M Goldberg
Adjuvant chemotherapy for colon cancer.
Current oncology reports 2001;3(2):94-101.
2001: C Erlichman; Richard M Goldberg; M J O'Connell
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
The New England journal of medicine 2001;344(4):305; author reply 306-7.
2000: Richard M Goldberg
Oxaliplatin in colorectal cancer: current studies.
Oncology (Williston Park, N.Y.) 2000;14(12 Suppl 11):42-7.
2000: Henry C Pitot; James A Knost; Michelle R Mahoney; J Kugler; James E Krook; Alan K Hatfield; Daniel J Sargent; Richard M Goldberg
A North Central Cancer Treatment Group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma.
Cancer 2000;89(8):1699-705.
2000: Patrick A Burch; C Ghosh; Georgene Schroeder; Cristine Allmer; C L Woodhouse; Richard M Goldberg; Ferdinand K Addo; Albert M Bernath; Loren K Tschetter; Harold E Windschitl; Charles D Cobau
Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial.
American journal of clinical oncology 2000;23(5):534-7.
2000: Daniel J Sargent; Richard M Goldberg; Michelle R Mahoney; D W Hillman; T McKeough; S F Hamilton; J M Darcy; V L Anderson; James E Krook; Michael J O'Connell
Rapid reporting and review of an increased incidence of a known adverse event.
Journal of the National Cancer Institute 2000;92(12):1011-3.
2000: Henry C Pitot; Richard M Goldberg; Joel M Reid; Jeff A Sloan; P A Skaff; Charles Erlichman; Joseph Rubin; P A Burch; Alex A. Adjei; S A Alberts; L J Schaaf; Gary L Elfring; Langdon L Miller
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2236-44.
2000: Alex A. Adjei; Charles Erlichman; Jeff A Sloan; Joel M Reid; Henry C Pitot; Richard M Goldberg; Prema P Peethambaram; Pamela J Atherton; Lorelei J Hanson; Steven R Alberts; James Jett
Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1748-57.
2000: Alex A. Adjei; Cheri E Klein; Helen Kastrissios; Richard M Goldberg; Steven R Alberts; Henry C Pitot; Jeff A Sloan; Joel M Reid; Lorelei J Hanson; Pamela J Atherton; Joseph Rubin; Charles Erlichman
Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(5):1116-23.
2000: A Jatoi; C L Loprinzi; J Sloan; Richard M Goldberg
Is ATP (adenosine 5'-triphosphate), like STP, a performance-enhancing additive for the tanks of cancer patients?
Journal of the National Cancer Institute 2000;92(4):290-1.
1999: Kevin C Halling; Amy J French; Shannon K McDonnell; Lawrence J Burgart; Daniel J Schaid; Brett J Peterson; L Moon-Tasson; M R Mahoney; Daniel J Sargent; Michael J O'Connell; Thomas E Witzig; Gist Henry Farr; Richard M Goldberg; Stephen N Thibodeau
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.
Journal of the National Cancer Institute 1999;91(15):1295-303.
1999: C Erlichman; Richard M Goldberg; H C Pitot; M J O'Connell
Optimum doses of irinotecan.
Lancet 1999;353(9160):1275-6.
1999: Henry C Pitot; EA McElroy; Joel M Reid; A J Windebank; Jeff A Sloan; Charles Erlichman; Pamela G Bagniewski; Denise L Walker; Joseph Rubin; Richard M Goldberg; Alex A. Adjei; Matthew M Ames
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(3):525-31.
1999: Richard M Goldberg; C L Loprinzi
Cancer anorexia/cachexia.
Cancer treatment and research 1999;100():31-41.
1998: Richard M Goldberg
Is repeated treatment with a 5-fluorouracil-based regimen useful in colorectal cancer?
Seminars in oncology 1998;25(5 Suppl 11):21-8.
1998: Steven R Alberts; Charles Erlichman; Joel M Reid; Jeff A Sloan; Matthew M Ames; Ronald L Richardson; Richard M Goldberg
Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(9):2111-7.
1998: Richard M Goldberg; C Erlichman
Irinotecan plus 5-FU and leucovorin in advanced colorectal cancer: North American trials.
Oncology (Williston Park, N.Y.) 1998;12(8 Suppl 6):59-63.
1998: Richard M Goldberg; T R Fleming; C M Tangen; CG Moertel; J S Macdonald; D G Haller; John A Laurie
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group.
Annals of internal medicine 1998;129(1):27-35.
1997: Richard M Goldberg; Joel M Reid; Matthew M Ames; J A Sloan; J Rubin; C Erlichman; Mary J Kuffel; T R Fitch
Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factor.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2363-70.
1997: Richard M Goldberg; Alan K Hatfield; M Kahn; Daniel J Sargent; James A Knost; Michael J O'Connell; James E Krook; J A Maillard; Martin Wiesenfeld; Paul L Schaefer; Maria Tria Tirona; CG Moertel
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3320-9.
1997: Henry C Pitot; Donald B Wender; Michael J O'Connell; Georgene Schroeder; Richard M Goldberg; Joseph Rubin; James A Mailliard; James A Knost; C Ghosh; RJ Kirschling; Ralph Levitt; Harold E Windschitl
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2910-9.
1996: Terrence L Cascino; Michael H Veeder; Jan C Buckner; Judith R O'Fallon; M Wiesenfeld; Ralph Levitt; Richard M Goldberg; Steven A Kuross; Roscoe F Morton; Bernd W Scheithauer
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor.
Journal of neuro-oncology 1996;30(3):243-6.
1996: M J O'Connell; M J Kahn; C Erlichman; Richard M Goldberg; L E Shepherd
Optimal duration of fluorouracil plus levamisole colon cancer surgical adjuvant therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2887.
1996: J T Schleusener; H D Tazelaar; S H Jung; S S Cha; P J Cera; Jeffrey L Myers; Edward T. Creagan; Richard M Goldberg; R F Marschke
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma.
Cancer 1996;77(7):1284-91.
1995: Richard M Goldberg; Charles L Loprinzi; James A Mailliard; Judith R O'Fallon; James E Krook; C Ghosh; R D Hestorff; S F Chong; N F Reuter; T G Shanahan
Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2856-9.
1995: Richard M Goldberg; CG Moertel; H S Wieand; James E Krook; A J Schutt; Michael H Veeder; James A Mailliard; Robert J Dalton
A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. North Central Cancer Treatment Group and the Mayo Clinic.
Cancer 1995;76(6):961-6.
1995: Ralph Levitt; Jan C Buckner; Terrence L Cascino; Patrick A Burch; Roscoe F Morton; M W Westberg; Richard M Goldberg; J G Gallagher; Judith R O'Fallon; B W Scheithauer
Phase II study of amonafide in patients with recurrent glioma.
Journal of neuro-oncology 1995;23(1):87-93.
1994: James R Jett; J Q Su; James E Krook; Richard M Goldberg; John W Kugler
Measurable or assessable disease in lung cancer trials: does it matter?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2677-81.
1994: L D Erickson; Lynn C Hartmann; J Q Su; S N Nielsen; D M Pfeifel; Richard M Goldberg; Ralph Levitt; C Robert Stanhope
Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinoma.
Gynecologic oncology 1994;54(2):196-200.
1994: H J Long; R A Nelimark; J Q Su; S C Garneau; Ralph Levitt; Richard M Goldberg; M A Poon; John W Kugler
Phase II evaluation of 5-fluorouracil and low-dose leucovorin in cisplatin-refractory advanced ovarian carcinoma.
Gynecologic oncology 1994;54(2):180-3.
1994: Charles L Loprinzi; Richard M Goldberg; J Q Su; James A Mailliard; Steven A Kuross; A W Maksymiuk; John W Kugler; James R Jett; C Ghosh; D M Pfeifle
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1126-9.
1994: Charles L Loprinzi; Steven A Kuross; Judith R O'Fallon; Dean H Gesme; JB Gerstner; R M Rospond; C D Cobau; Richard M Goldberg
Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1121-5.
1994: James N Ingle; J F Foley; James A Mailliard; James E Krook; Lynn C Hartmann; S H Jung; Michael H Veeder; Dean H Gesme; Alan K Hatfield; Richard M Goldberg
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer.
Cancer 1994;73(9):2337-43.
1994: Charles L Loprinzi; Richard M Goldberg; Judith R O'Fallon; Susan K Quella; A W Miser; L A Mynderse; L D Brown; Loren K Tschetter; M B Wilwerding; M Dose
Transdermal clonidine for ameliorating post-orchiectomy hot flashes.
The Journal of urology 1994;151(3):634-6.
1994: Richard M Goldberg; Charles L Loprinzi; Judith R O'Fallon; Michael H Veeder; A W Miser; James A Mailliard; John C Michalak; A M Dose; Kendrith M Rowland; N L Burnham
Transdermal clonidine for ameliorating tamoxifen-induced hot flashes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):155-8.
1993: Charles L Loprinzi; John C Michalak; Daniel J Schaid; James A Mailliard; L M Athmann; Richard M Goldberg; Loren K Tschetter; Alan K Hatfield; Roscoe F Morton
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):762-7.
1992: Charles L Loprinzi; Richard M Goldberg; N L Burnham
Cancer-associated anorexia and cachexia. Implications for drug therapy.
Drugs 1992;43(4):499-506.
1991: H J LONG; H S Wieand; J F Foley; R D Niedringhaus; J A Laurie; Roscoe F Morton; Richard M Goldberg; James A Mailliard; G D Malkasian; J H Edmonson
Phase II evaluation of menogaril in patients with advanced cervical carcinoma. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.
Investigational new drugs 1991;9(4):349-51.
1991: J D Ahlgren; O Trocki; J J Gullo; Richard M Goldberg; W A Muir; R Sisk; L Schacter
Protracted infusion of 5-FU with weekly low-dose cisplatin as second-line therapy in patients with metastatic colorectal cancer who have failed 5-FU monotherapy.
Cancer investigation 1991;9(1):27-33.
1990: Richard M Goldberg; James R Jett; T M Therneau; P S Johnson; Loren K Tschetter; James E Krook; Michael H Veeder; D Owen; P S Etzell; D F Andres
Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment group.
Journal of the National Cancer Institute 1990;82(24):1899-903.
1990: Charles L Loprinzi; N M Ellison; Richard M Goldberg; John C Michalak; Patrick A Burch
Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
Seminars in oncology 1990;17(6 Suppl 9):8-12.
1990: Harold E Windschitl; Michael J O'Connell; H S Wieand; James E Krook; Joseph Rubin; CG Moertel; John W Kugler; D M Pfeifle; Richard M Goldberg; J A Laurie
A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer.
Cancer 1990;66(5):853-6.
1989: Louis Letendre; R D Niedringhaus; Terry M Therneau; Dennis A Gastineau; Richard M Goldberg; JB Gerstner; James A Mailliard; W J Gundlach; C G Kardinal; R V Pierre
Treatment of acute nonlymphocytic leukemia in the elderly with intermediate high-dose cytosine arabinoside.
Medical and pediatric oncology 1989;17(2):79-82.
1986: Richard M Goldberg; F P Smith; W Ueno; J D Ahlgren; P S Schein
5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(3):395-9.
1986: S Korec; P S Schein; F P Smith; J R Neefe; P V Woolley; Richard M Goldberg; T M Phillips
Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(2):210-5.
1985: D Stefanik; Richard M Goldberg; P Byrne; F Smith; W Ueno; L Smith; L Bachenheimer; C Beiser; A Dritschilo
Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(5):660-5.